Cost effectiveness of computer tailored and non-tailored smoking cessation letters in general practice: randomised controlled trial Autor Lennox, A, Osman, L, Reiter, E, Robertson, R, Friend, J, McCann, I, Skatun, D, Donnan, P

'Cut down to quit' with nicotine replacement therapies in smoking cessation: a systematic review of effectiveness and economic analysis. Autor Wang, D, Connock, M, Barton, P, Fry-Smith, A, Aveyard, P, Moore, D

“…However, sustained smoking cessation was only reported as a secondary outcome in these trials and required commencement of cessation within the first 6 weeks of treatment. …”

Adherence to and consumption of nicotine replacement therapy and the relationship with abstinence within a smoking cessation trial in primary care. Autor Hollands, G, Sutton, S, McDermott, MS, Marteau, T, Aveyard, P

“…METHODS: Secondary analysis of data from a randomized controlled trial conducted in smoking cessation services in primary care. Adult smokers (n = 633) starting a quit attempt within smoking cessation clinics were followed for 6 months, with NRT use closely monitored for an initial treatment period of 4 weeks. …”

Smoking cessation in adults with diabetes: a systematic review and meta-analysis of data from randomised controlled trials. Autor Nagrebetsky, A, Brettell, R, Roberts, N, Farmer, A

“…OBJECTIVES: To evaluate the effects of more intensive smoking cessation interventions compared to less intensive interventions on smoking cessation in people with type 1 or type 2 diabetes. …”

The association of smoking cessation with HbA(1c) control of diabetes mellitus: a THIN database study Autor Nichols, L, Ryan, R, Farley, A, Roalfe, A, Mohammed, M, Szatkowski, L, Coleman, T, Morris, R, Farmer, A, Aveyard, P, Lycett, D

An update of a systematic review and meta-analyses exploring flavours in intervention studies of e-cigarettes for smoking cessation Autor Lindson, N, Livingstone-Banks, J, Butler, A, Levy, D, Barnett, P, Theodoulou, A, Notley, C, Rigotti, N, Chen, Y, Hartmann-Boyce, J

“…Studies provided adults who smoked cigarettes with nicotinecontaining e-cigarettes for smoking cessation and provided data on e-cigarette e-liquid flavour use. …”

How important is the smoking status of the Woman's partner as a predictor of smoking cessation in pregnancy? A literature review Autor Ziebland, S, Mathews, F

“…The aim of this-paper is to assess the extent to which the smoking status of a pregnant woman's partner is. a predictor or correlate of smoking cessation Or relapse. A systematic review of the literature (including surveys with and without follow-ups, trials and evaluations) identified 62 papers on smoking and pregnancy, which included 25 studies in which the smoking status of the' woman's partner (or 'other in household') was reported. …”

How does bupropion compare with varenicline or nicotine replacement therapies (NRTs) for promoting smoking cessation in adolescents and adults? Autor Livingstone-Banks, JE

An exploration of flavours in studies of e-cigarettes for smoking cessation: secondary analyses of a systematic review with meta-analyses Autor Lindson, N, Butler, AR, Liber, A, Levy, DT, Barnett, P, Theodoulou, A, Notley, C, Rigotti, NA, Hartmann-Boyce, J

“…<p><strong>Aims:</strong>&nbsp;To estimate associations between e-cigarette flavour and smoking cessation and study product use at 6&nbsp;months or longer.…”

'Cut down to quit' with nicotine replacement therapies in smoking cessation: a systematic review of effectiveness and economic analysis. Autor Wang, D, Connock, M, Barton, P, Fry-Smith, A, Aveyard, P, Moore, D

“…However, sustained smoking cessation was only reported as a secondary outcome in these trials and required commencement of cessation within the first 6 weeks of treatment. …”

Enhancing behavior change technique coding methods: Identifying behavioral targets and delivery styles in smoking cessation trials Autor Black, N, Williams, A, Javornik, N, Scott, C, Johnston, M, Eisma, M, Michie, S, Hartmann-Boyce, J, West, R, Viechtbauer, W, De Bruin, M

“…<strong>Conclusions</strong> Behavioral targets and delivery styles of BCTs can be reliably identified and occur with sufficient frequency in smoking cessation trials for inclusion in quantitative syntheses (e.g., meta-regression analyses). …”

STOP— a training intervention to optimise treatment for smoking cessation in community pharmacies: cluster randomised controlled trial Autor Jumbe, S, Madurasinghe, VW, James, WY, Houlihan, C, Jumbe, SL, Yau, T, Tomini, F, Eldridge, S, Mihaylova, B, Steed, L, Sohanpal, R, Attar, D, Taylor, SJC, Griffiths, C, Walton, R

Cytisine versus varenicline for smoking cessation in a primary care setting: a randomized non-inferiority trial Autor Oreskovic, T, Percac-Lima, S, Ashburner, JM, Tiljak, H, Rifel, J, Klemenc Ketiš, Z, Oreskovic, S

“…<p><strong>Introduction: </strong>A smoking-cessation program was implemented as a randomized non-inferiority trial in primary care practices in Croatia and Slovenia to investigate whether a standard 4-week treatment with cytisine was at least as effective and feasible as a standard 12-week treatment with varenicline in helping smokers quit.…”

Cost effectiveness of computer tailored and non-tailored smoking cessation letters in general practice: randomised controlled trial. Autor Lennox, A, Osman, L, Reiter, E, Robertson, R, Friend, J, McCann, I, Skatun, D, Donnan, P

“…OBJECTIVES: To develop and evaluate, in a primary care setting, a computerised system for generating tailored letters about smoking cessation. DESIGN: Randomised controlled trial. …”

Smoking cessation policy and treatments derived from the protective motivation of smokers: a study on graphic health warning labels Autor Pang, Qiwei, Wang, Lu, Yao, Jinge, Yuen, Kum Fai, Su, Miao, Fang, Mingjie

Získat plný text

The clinical effectiveness and cost-effectiveness of bupropion and nicotine replacement therapy for smoking cessation: a systematic review and economic evaluation. Autor Woolacott, N, Jones, L, Forbes, C, Mather, L, Sowden, A, Song, F, Raftery, J, Aveyard, P, Hyde, C, Barton, P

Association between use of nicotine replacement therapy for harm reduction and smoking cessation: a prospective study of English smokers. Autor Beard, E, McNeill, A, Aveyard, P, Fidler, J, Michie, S, West, R

Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies. Autor Peto, R, Darby, S, Deo, H, Silcocks, P, Whitley, E, Doll, R

“… OBJECTIVE AND DESIGN: To relate UK national trends since 1950 in smoking, in smoking cessation, and in lung cancer to the contrasting results from two large case-control studies centred around 1950 and 1990. …”

The clinical effectiveness and cost-effectiveness of bupropion and nicotine replacement therapy for smoking cessation: A systematic review and economic evaluation Autor Woolacott, N, Jones, L, Forbes, C, Mather, L, Sowden, A, Song, F, Raftery, J, Aveyard, P, Hyde, C, Barton, P

Association of smoking and smoking cessation with major causes of mortality in the Asia Pacific Region: the Asia Pacific Cohort Studies Collaboration Autor Barzi, F, Huxley, R, Jamrozik, K, Lam, T, Ueshima, H, Gu, D, Kim, H, Woodward, M